Tsukasa Murata

8PUBLICATIONS
7CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Chemical engineering designMolecular medicineTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 17, 2026
Serum Prolactin Levels as an Intraindividual Biomarker for Guiding Osmotic-Release Oral System-Methylphenidate Therapy: Three Case Reports.

Tsukasa Murata, Maiko Nagaoka, Masakatsu Sakamoto

|Nov 07, 2025
Medication Adjustments in a Schizophrenia Patient With Obesity and Asthma During COVID-19 Infection.

Tsukasa Murata, Shiro Furusho, Takahiko Nagamine

|Oct 31, 2025
Molnupiravir: Clinical Impact of Fenofibrate, a Carboxylesterase 2 Inhibitor.

Tsukasa Murata, Masakatsu Sakamoto, Takahiko Nagamine

|May 08, 2025
Memantine-Associated Decrease in Renal Function and Hyperuricemia.

Tsukasa Murata, Yusuke Yamaguchi, Yuki Kurauchi

|Jul 09, 2024
Effect of concomitant use of yokukansan on steady-state blood concentrations of donepezil and risperidone in real-world clinical practice.

Junji Saruwatari, Tetsuya Kaneko, Tsukasa Murata

|Jul 08, 2024
Methylphenidate-Associated Creatine Kinase Level Elevation.

Maiko Nagaoka, Tsukasa Murata, Takahiko Nagamine

Pageof 2

Frequent Collaborators

2 joint publications

Takahiko Nagamine

1 joint publications

Junji Saruwatari

1 joint publications

Kazutaka Oda

1 joint publications

Hirofumi Jono